US Patent 9272001 Ablative immunotherapy
Patent 9272001 was granted and assigned to Immunovative Therapies on March, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9272001 Ablative immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
